Bionik Laboratories Corp. Annual Cost of Revenue in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Bionik Laboratories Corp. quarterly/annual Cost of Revenue history and growth rate from 2013 to 2022.
  • Bionik Laboratories Corp. Cost of Revenue for the quarter ending March 31, 2023 was $247K, a 321% increase year-over-year.
  • Bionik Laboratories Corp. Cost of Revenue for the twelve months ending March 31, 2023 was $815K, a 154% increase year-over-year.
  • Bionik Laboratories Corp. annual Cost of Revenue for 2022 was $815K, a 154% increase from 2021.
  • Bionik Laboratories Corp. annual Cost of Revenue for 2021 was $320K, a 18.8% increase from 2020.
  • Bionik Laboratories Corp. annual Cost of Revenue for 2020 was $270K, a 69.8% decline from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $815K +$495K +154% Apr 1, 2022 Mar 31, 2023 10-K 2023-06-21
2021 $320K +$50.8K +18.8% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-21
2020 $270K -$624K -69.8% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-09
2019 $893K Apr 1, 2019 Mar 31, 2020 10-K 2021-06-24
2014 $7K +$7K Jan 1, 2014 Dec 31, 2014 10-K 2015-04-15
2013 $0 Jan 1, 2013 Dec 31, 2013 10-K 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.